BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 45 filers reported holding BOLT BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,602,640 | -18.8% | 1,541,000 | 0.0% | 0.03% | -5.6% |
Q2 2023 | $1,972,480 | -7.9% | 1,541,000 | 0.0% | 0.04% | -14.3% |
Q1 2023 | $2,141,990 | +113.7% | 1,541,000 | +99.9% | 0.04% | +121.1% |
Q4 2022 | $1,002,377 | -12.1% | 771,059 | 0.0% | 0.02% | -9.5% |
Q3 2022 | $1,141,000 | – | 771,059 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $23,927,000 | 8.46% |
Nan Fung Group Holdings Ltd | 1,166,952 | $14,762,000 | 4.72% |
Novo Holdings A/S | 4,503,991 | $56,975,000 | 2.95% |
Vivo Capital, LLC | 3,871,291 | $48,972,000 | 2.20% |
Sofinnova Investments, Inc. | 2,754,437 | $34,844,000 | 2.06% |
Samsara BioCapital, LLC | 737,459 | $9,329,000 | 1.46% |
Ally Bridge Group (NY) LLC | 257,267 | $3,254,000 | 0.96% |
Board of Trustees of The Leland Stanford Junior University | 719,546 | $9,102,000 | 0.68% |
Rock Springs Capital Management LP | 1,649,248 | $20,863,000 | 0.44% |
RA Capital Management | 2,378,325 | $30,086,000 | 0.42% |